Latest news
Sanofi asked to change Dupixent ads after Galderma challenge - fiercepharma.comfiercepharma.com · Thu, 06 Aug 2026 11:40:54 GMTNational Advertising Division Finds Certain DUPIXENT Claims - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 17:00:00 GMTNational Advertising Division Finds Certain DUPIXENT Claims Supported; Recommends Sanofi Modify or Discontinue Other Claims - Yahoo Finance SingaporeYahoo Finance Singapore · Wed, 05 Aug 2026 17:00:00 GMTAttovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 10:58:58 GMTRegeneron: Dupixent Sales Reach $6 Billion As Sanofi Repayment Unlocks Profit And Cash Flow Inflection - Pulse 2.0Pulse 2.0 · Sun, 02 Aug 2026 21:22:29 GMTSanofi drug pipeline worries, Dupixent dependence shake shares - ReutersReuters · Thu, 30 Jul 2026 19:41:50 GMTRegeneron, Sanofi tease potential expanded collaboration for Dupixent follow-ons - Endpoints NewsEndpoints News · Thu, 30 Jul 2026 19:24:32 GMTSanofi raises outlook as quarterly Dupixent sales cross €5B for first time - FirstWord PharmaFirstWord Pharma · Thu, 30 Jul 2026 15:21:36 GMT